Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Abbvie Ltd | 08004972 | £986,282,758 | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Accord-UK Ltd | 00079585 | £986,282,758 | - |
| Alexion Pharmaceuticals | - | £986,282,758 | - |
| Amgen Ltd | 02354269 | £986,282,758 | - |
| Biogen | 06151086 | £986,282,758 | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | £986,282,758 | - |
| CuraTeQ Biologics s.r.o. | - | £986,282,758 | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | £986,282,758 | - |
| Fresenius Kabi Limited | 02182135 | £986,282,758 | - |
| GlaxoSmithKline UK Limited | 04310159 | £986,282,758 | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| Janssen-Cilag Ltd | 01027904 | £986,282,758 | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Organon Pharmaceuticals UK Ltd | - | £986,282,758 | - |
| Orifarm UK | 10015046 | £986,282,758 | - |
| Pfizer Ltd | 00526209 | £986,282,758 | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | £986,282,758 | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Samsung Bioepis UK Ltd | 08840722 | £986,282,758 | - |
| Sandoz Ltd | 01547204 | £986,282,758 | - |
| Sobi (Swedish Orphan Biovitrum Ltd) | - | £986,282,758 | - |
| Takeda UK Ltd | 03362860 | £986,282,758 | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| Thornton and Ross Ltd | 00185947 | £986,282,758 | - |
| Zentiva Pharma UK Ltd | 02158996 | £986,282,758 | - |
Government spending data: These suppliers have received £788,699,292 in 7,346 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS Supply Chain (DHSC-funded), NHS England, Manchester University NHS Foundation Trust and 20 more public bodies (2010-04-28 to 2026-03-31).